Advanced search
Publication Cover
Gynecological Endocrinology Volume 26, 2010 - Issue 2
Submit an article Journal homepage
70
Views
1
CrossRef citations to date
0
Altmetric
PCOS

Pregnancy in a woman with polycystic ovary syndrome and myelodysplastic syndrome (in the form of refractory anemia) treated with allogeneic hemopoietic stem-cell transplantation (alloHSCT)

Lidia Usnarska-ZubkiewiczDepartment and Clinic of Haematology, Blood Neoplasms, and Bone Marrow Transplantation, Wrocaw Medical University, Wrocaw, PolandCorrespondence[email protected]
,
Marek BolanowskiDepartment and Clinic of Endocrinology, Diabetology and Isotope Therapy, Wrocaw Medical University, Wrocaw, Poland
,
Agnieszka Zubkiewicz-KucharskaDepartment and Clinic of Endocrinology and Diabetology for Children and Adolescents, Wrocaw Medical University, Wrocaw, Poland
,
Maria Podolak-DawidziakDepartment and Clinic of Haematology, Blood Neoplasms, and Bone Marrow Transplantation, Wrocaw Medical University, Wrocaw, Poland
&
Kazimierz KuliczkowskiDepartment and Clinic of Haematology, Blood Neoplasms, and Bone Marrow Transplantation, Wrocaw Medical University, Wrocaw, Poland
Pages 135-138 | Received 18 Mar 2009, Accepted 20 Jul 2009, Published online: 15 Jan 2010

References

  • Smith MT, Linet MS, Morgan GJ. Causative agents in the etiology of myelodysplastic syndromes and the acute myeloid leukemias. In: Bennett JM, editor. Myelodysplastic syndromes: pathobiology and clinical management. New York: Marcel Dekker Inc; 2002.
  • Hellström-Lindberg E, Malcovati L. Supportive care, growth factors and new therapies in myelodysplastic syndromes. Blood Rev 2008;22:75–91.
  • Jäderstem M, Montgomery SM, Dybedal I, Porwit-MacDonald A, Hellström-Lindberg E. Long outcome of treatment of anemia in MDS with erythropoietin and G-CSF. Blood 2005;106:803–811.
  • Hellström-Lindberg E, Gulbrandsen N, Lindberg G, Ahlgren T, Dahl IM, Dybedal I, Grimfors G, Hesse-Sundin E, Hjorth M, Kanter-Lewensohn L, et al A validated decision model for treating the anemia of myelodysplastic syndrome with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life. Br J Haematol 2003;120:1037–1046.
  • Deeg HJ, Storer B, Slattery JT, Anasetti C, Doney KC, Hansen JA, Kiem HP, Martin PJ, Petersdorf E, Radich JP, et al Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome. Blood 2002;100:1201–1207.
  • Sierra J, Pérez WS, Rozman C, Carreras E, Klein JP, Rizzo JD, Davies SM, Lazarus HM, Bredeson CN, Marks DI, et al Bone marrow transplantation from HLA-identical sibling as treatment for myelodysplasia. Blood 2002;100:1997–2004.
  • The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–47.
  • Couto-Silva AC, Trivin C, Thibaud E, Esperou H, Michon J, Brauner R. Post transplant complication. Factors affecting gonadal function after bone marrow transplantation during childhood. Bone Marrow Transplat 2001;28:67–75.
  • Wallace WH, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer. Who is at risk and what can be offered? Lancet Oncol 2005;6:209–218.
  • Meirow D. Reproduction post-chemotherapy in young cancer patients. Mol Cell Endocrinol 2000;169:123–133.
  • Teinturier C, Hartmann O, Valteau-Couanet D, Benhamou E, Bougneres PF. Ovarian function after autologous bone marrow transplantation in childhood: High-dose busulfan is a major cause of ovarian failure. Bone Marrow Transplant 1998;22:989–994.
  • Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, Doney K, Storb R, Sullivan K, Witherspoon R, et al Pregnancies following high dose cyclophosphamide with or without high dose busulphan or total body irradiation and bone marrow transplantation. Blood 1996;87:3045–3052.
  • Lobo RA. Potential options for preservation of fertility in women. N Engl J Med 2005;353:64–73.
  • Gropp M, Meier W, Hepp H. Treosulfan as an effective second-line therapy in ovarian cancer. Gynecol Oncol 1998;71:94–98.
  • Beelen DW, Trenschel R, Casper J, Freund M, Hilger RA, Scheulen ME, Basara N, Fauser AA, Hertenstein B, Mylius HA, et al Dose escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with increased risk for regimen-related complication. Bone Marrow Transplant 2005;35:233–241.
  • Mlćochova H, Hořejši J, Martinek J, Vetešniková-Koubová R, Halaška M. Treatment of autoimmune ovarian damage in adolescent girls. Neuro Endocrinol Lett 2005;26:131–135.
  • Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ. Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril 2008 Dec 3. Epub ahead of print.
  • Boomsma CM, Fauser BC, Macklon NS. Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med 2008;26:72–84.
  • Espinos Gomez JJ, Corcoy R, Calaf J. Prevalence and predictors of abnormal glucose metabolism in Mediterranean woman with polycystic ovary syndrome. Gynecol Endocrinol 2009;25:199–204.
  • Salooja N, Szydlo RM, Socie G, Rio B, Chatterjee R, Ljungman P, Van Lint MT, Powles R, Jackson G, Hinterberger-Fischer M, Kolb HJ, et al Late effects working party of the European group for blood and marrow transplantationl: pregnancy outcomes after peripheral blood and bone marrow transplantation: a retrospective survey. Lancet 2001;358:271–276.
  • Wielgos M, Pietrzak B, Bobkowska K, Bablok L, Kaminski P. Pregnancy after organ transplantation. Neuro Endocrinol Lett 2009;30:6–10.
  • Gulati SC, Van Poznak C. Pregnancy after bone marrow transplantation. J Clin Oncol 1998;16:1978–1985.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.